Clinical Trial Update: A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2A trial of EPI-743 for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• EPI-743

Snippet

Sponsor: University of South Florida | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED